S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden To Unleash "Choke Point" Operation On America? (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden To Unleash "Choke Point" Operation On America? (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden To Unleash "Choke Point" Operation On America? (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Biden To Unleash "Choke Point" Operation On America? (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Biden To Unleash "Choke Point" Operation On America? (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
OTCMKTS:VASO

Vaso - VASO Earnings Date, Estimates & Call Transcripts

$0.23
-0.01 (-4.24%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.22
$0.24
50-Day Range
$0.18
$0.29
52-Week Range
$0.06
$0.29
Volume
14,881 shs
Average Volume
105,245 shs
Market Capitalization
$39.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Skip Charts & View Estimated and Actual Earnings Data

VASO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VASO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

VASO Earnings Date and Information

Vaso has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 15th, 2023 based off prior year's report dates.

Vaso Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/15/2023
(Estimated)
        
11/14/2022Q3 2022$0.01+$0.01$0.01$20.04 million
8/15/2022Q2 2022$0.01+$0.01$0.01$19.50 million
8/16/2021Q2 2021$0.02+$0.02$0.02$16.13 million
11/13/2020Q3 2020$0.01+$0.01$0.01$17.53 million
6/4/2020Q1 2020($0.01)($0.01)($0.01)$17.28 million
4/14/2020Q4 2019$0.02+$0.02$0.02$23.95 million
8/14/2019Q2 2019($0.0045)($0.0045)$17.54 million
5/15/2019Q1 2019($0.02)($0.02)($0.02)$15.52 million
5/15/2018Q1 2018($0.01)($0.01)($0.01)$17.54 million  
8/14/2017Q2 2017($0.01)($0.01)($0.01)$17.85 million
5/15/2017Q1 2017($0.01)($0.01)($0.01)$16.37 million
3/30/2016Q4 2015$0.01+$0.01$0.01$21.38 million
11/13/2015Q3 2015($0.01)($0.01)($0.01)$17.40 million
3/30/2015Q4 2014$0.02+$0.02$0.02$12.36 million
5/14/2014Q1 2014($0.01)($0.01)($0.01)$7.09 million
11/20/2012Q3 2012($0.02)($0.02)($0.02)
5/15/2012Q1 2012($0.01)($0.01)($0.01)
1/17/2012Q4 2011$0.01+$0.01$0.01
10/17/2011Q3 2011($0.01)($0.01)($0.01)
8/30/2011Q2 2011($0.01)($0.01)($0.01)
1/18/2011Q4 2010($0.01)($0.01)($0.01)
10/15/2008Q3 2008($0.01)($0.01)($0.01)












Vaso Earnings - Frequently Asked Questions

When is Vaso's earnings date?

Vaso has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 15th, 2023 based off last year's report dates. Learn more on VASO's earnings history.

How much revenue does Vaso generate each year?

Vaso (OTCMKTS:VASO) has a recorded annual revenue of $75.58 million.

How much profit does Vaso generate each year?

Vaso (OTCMKTS:VASO) has a recorded net income of $6.10 million. VASO has generated $0.00 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (OTCMKTS:VASO) was last updated on 3/29/2023 by MarketBeat.com Staff